chr12-14840920-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_021071.4(ART4):āc.378T>Cā(p.Tyr126=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 1,614,000 control chromosomes in the GnomAD database, including 103,376 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.32 ( 8334 hom., cov: 32)
Exomes š: 0.35 ( 95042 hom. )
Consequence
ART4
NM_021071.4 synonymous
NM_021071.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0410
Genes affected
ART4 (HGNC:726): (ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)) This gene encodes a protein that contains a mono-ADP-ribosylation (ART) motif. It is a member of the ADP-ribosyltransferase gene family but enzymatic activity has not been demonstrated experimentally. Antigens of the Dombrock blood group system are located on the gene product, which is glycosylphosphatidylinosotol-anchored to the erythrocyte membrane. Allelic variants, some of which lead to adverse transfusion reactions, are known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 12-14840920-A-G is Benign according to our data. Variant chr12-14840920-A-G is described in ClinVar as [Benign]. Clinvar id is 3060314.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.041 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.366 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ART4 | NM_021071.4 | c.378T>C | p.Tyr126= | synonymous_variant | 2/3 | ENST00000228936.6 | NP_066549.2 | |
ART4 | NM_001354646.2 | c.378T>C | p.Tyr126= | synonymous_variant | 2/2 | NP_001341575.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ART4 | ENST00000228936.6 | c.378T>C | p.Tyr126= | synonymous_variant | 2/3 | 1 | NM_021071.4 | ENSP00000228936 | P1 |
Frequencies
GnomAD3 genomes AF: 0.321 AC: 48784AN: 152010Hom.: 8322 Cov.: 32
GnomAD3 genomes
AF:
AC:
48784
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.317 AC: 79720AN: 251178Hom.: 13507 AF XY: 0.321 AC XY: 43592AN XY: 135728
GnomAD3 exomes
AF:
AC:
79720
AN:
251178
Hom.:
AF XY:
AC XY:
43592
AN XY:
135728
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.355 AC: 518609AN: 1461872Hom.: 95042 Cov.: 57 AF XY: 0.353 AC XY: 256863AN XY: 727234
GnomAD4 exome
AF:
AC:
518609
AN:
1461872
Hom.:
Cov.:
57
AF XY:
AC XY:
256863
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.321 AC: 48816AN: 152128Hom.: 8334 Cov.: 32 AF XY: 0.315 AC XY: 23446AN XY: 74360
GnomAD4 genome
AF:
AC:
48816
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
23446
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
628
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ART4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at